Market News AIOpen the app

OS Therapies has started the process to get approval for Herlystic in the U.K. to help prevent cancer from coming back.

TrialRead the original at natlawreview.com
Good for OSTX

OS Therapies has started a U.K. application process for Herlystic, moving it closer to possible use there. The process is not complete, and the announcement reports no U.K. approval.

OSTX · OS Therapies

AI read · Good for OSTX

The AI's read

Starting this process gives OS Therapies a step toward seeking U.K. use for Herlystic. The treatment is intended for patients with a serious form of bone cancer that has spread to the lungs. The announcement reports a process, not permission to sell the treatment. Even so, starting the process is progress, so the news reads as favorable.

Get alerts for OSTX

Follow OS Therapies (OSTX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for OSTX
Free on the App Store and Google Play, or on the web.